Cempra (CEMP) Tops Q2 EPS by 16c; Updates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Needham & Company Remains Bullish on Cempra (CEMP) Following Conference Call with Management
August 2, 2016 8:19 AM EDTNeedham & Company reiterated a Buy rating and $48.00 price target on Cempra, Inc. (NASDAQ: CEMP) following a conference call with management. Management is expecting an FDA Advisory Committee meeting for Solithera in October or November 2016 and guided for a U.S. launch in Jan 2017.... More
